EggLogics is a company focused on the research and development of technologies for human fertility enhancement and restoration. With a team of experts from reproductive medicine, genomics, biomedical engineering, and computer sciences, Egglogics is developing novel solutions to increase the success rate of assisted reproductive technology (ART). They have invented a non-invasive method to improve the quantity and quality of usable oocytes, boosting the success rate of IVF. Egg donors or stem cells is not needed as opposed to other existing solutions. Their clinical trial is carried out at the IVF center of the Chinese University of Hong Kong, and is still ongoing.